| Document Date: 2014-07-15 14:00:38
Open Document File Size: 113,58 KBShare Result on Facebook
City Cincinnati / / Company Antibiotics / Administrator Intellectual Property Department Provider Synergies L.L.C. / Provider Synergies L.L.C. / GlaxoSmithKline / / Country United States / / Currency CYP / / / Event FDA Phase / Product Issues / / IndustryTerm wound management / healthcare / pharmaceutical / / MedicalCondition both S. aureus / Pseudomonas / allergic contact dermatitis / pus / Application Site Irritation Rash Pruritus Headache Diarrhea Nausea / soft-tissue infections / wound infection / methicillin-resistant S. aureus / both methicillinsensitive S. aureus / minor burn wound infection / impetigo / Haemophilus influenza / skin structure infections / infectious eczematoid dermatitis / skin infections / burns / psoriasis / Hypersensitivity / severe infections / soft tissue infections / infections / severe local irritation / skin infection / Most infections / furunculosis / Negative H. influenza Pseudomonas / superficial fungal infections / folliculitis / eczema / erythema / soft tissue bacterial infections / S. aureus / pustular acne / bacterial infection / common skin infections / pyoderma gangrenosum / pustular psoriasis / methicillin-sensitive S. aureus / infection / seborrheic dermatitis / contact dermatitis / renal failure / sycosis / / MedicalTreatment antibiotics / / OperatingSystem L3 / / Organization Pharmacy and Therapeutics committee / Infectious Diseases Society of America / FDA / Medicaid Agency / / Person Topical Mupirocin (Bactroban) / / Position physician / bacterial messenger / / Product cephalexin / ofloxacin / polyethylene glycol / gentamicin / mupirocin / polymyxin B sulfate / erythromycin / levofloxacin / bacitracin / Garamycin / Triple Antibiotic / Altabax / ketoconazole / ciprofloxacin / Bactroban / Gentamicin cream / Indications6 / B / Indications1 / 2 / 3 / 4 Drug / high risk / Mupirocin (Bactroban) cream / epithelium / / ProvinceOrState Ohio / /
SocialTag |
Microsoft Word - Antibiotics, Topical Mar 10 v2.doc